Munich - Delayed Quote EUR

BioCryst Pharmaceuticals Inc (BO1.MU)

Compare
6.85 -0.09 (-1.27%)
As of 8:00 AM GMT+2. Market Open.
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Assets
516,960.00
550,000.00
588,151.00
334,715.00
--
Total Liabilities Net Minority Interest
972,488.00
844,597.00
695,137.00
353,977.00
--
Total Equity Gross Minority Interest
-455,528.00
-294,597.00
-106,986.00
-19,262.00
--
Total Capitalization
355,737.00
438,682.00
478,471.00
225,190.00
--
Common Stock Equity
-455,528.00
-294,597.00
-106,986.00
-19,262.00
--
Capital Lease Obligations
13,883.00
8,173.00
7,781.00
5,050.00
--
Net Tangible Assets
-455,528.00
-294,597.00
-106,986.00
-19,262.00
--
Working Capital
345,978.00
410,986.00
462,418.00
218,146.00
--
Invested Capital
355,737.00
438,682.00
478,471.00
255,190.00
--
Tangible Book Value
-455,528.00
-294,597.00
-106,986.00
-19,262.00
--
Total Debt
825,148.00
741,452.00
593,238.00
279,502.00
--
Net Debt
700,622.00
428,512.00
81,068.00
2,325.00
--
Share Issued
205,771.00
187,906.00
184,350.00
176,883.00
--
Ordinary Shares Number
205,771.00
187,906.00
184,350.00
176,883.00
--
12/31/2019 - 9/11/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers